TPI T-Bird Pharma Inc.

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE
UNITED STATES


Tenth Power Technologies Corp. (TSX VENTURE:TPI) (the "Company" or "Tenth
Power") announced today that it is seeking the approval of the TSX Venture
Exchange to amend and replace its three (3) previously issued convertible
debentures (the "Debentures") of Tenth Power. The Company is seeking to
restructure the Debentures in order to streamline their terms such that the
revised debentures will have the same maturity date, coupon rate and conversion
price.


The Company plans to amend or replace the Debentures with debentures of an
aggregate face value of $1,593,676, maturing on October 31, 2014, having a
coupon rate of 7% per annum and fixed new conversion price of $0.10. The
replacement debentures will be unsecured obligations of Tenth Power. Interest
payments will be due semi-annually on April 30 and October 31.


The restructuring of the Debentures, if approved, will allow the Company to
simply the management and competiveness of the new debentures going forward.


ABOUT TENTH POWER TECHNOLOGIES CORP.

Tenth Power is a Canadian based technology and solutions company. The Company
provides bio identity technology, work flow and resource management platforms,
secure information transfer technology and innovative product development in
integration services. The Company's products and services are currently being
delivered in the Government and manufacturing sectors and are being prepared for
the financial services and health care markets.

Grafico Azioni T-Bird Pharma Inc. (TSXV:TPI)
Storico
Da Giu 2024 a Lug 2024

Grafico Azioni T-Bird Pharma Inc. (TSXV:TPI)
Storico
Da Lug 2023 a Lug 2024